Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2-6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands.

Autor: Wagenvoort GH; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands. Electronic address: wagenvoort@gmail.com., Sanders EA; Centre for Infectious Disease Control Netherlands (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Immunology and Infectious diseases, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, The Netherlands., Vlaminckx BJ; Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, The Netherlands., Elberse KE; Centre for Infectious Disease Control Netherlands (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., de Melker HE; Centre for Infectious Disease Control Netherlands (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands., van der Ende A; Department of Medical Microbiology and the Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, Amsterdam, The Netherlands., Knol MJ; Centre for Infectious Disease Control Netherlands (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Publikováno v: Vaccine [Vaccine] 2016 Feb 17; Vol. 34 (8), pp. 1077-85. Date of Electronic Publication: 2016 Jan 08.

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

Autor: Spijkerman J; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Centre, Utrecht, The Netherlands. j.spijkerman@umcutrecht.nl, Veenhoven RH, Wijmenga-Monsuur AJ, Elberse KE, van Gageldonk PG, Knol MJ, de Melker HE, Sanders EA, Schouls LM, Berbers GA

Publikováno v: JAMA [JAMA] 2013 Sep 04; Vol. 310 (9), pp. 930-7.

Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands.

Autor: Elberse KE; Laboratory for Infectious Diseases and Perinatal Screening, National Institute for Public Health and the Environment, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands. karin.elberse@rivm.nl, de Greeff SC, Wattimena N, Chew W, Schot CS, van de Pol JE, van der Heide JG, van der Ende A, van der Klis FR, Berbers GA, Schouls LM

Publikováno v: Vaccine [Vaccine] 2011 Jan 29; Vol. 29 (5), pp. 1029-35. Date of Electronic Publication: 2010 Dec 01.

Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing.

Autor: Elberse KE; Laboratory for Infectious Diseases and Perinatal Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Karin.Elberse@RIVM.nl, van de Pol I, Witteveen S, van der Heide HG, Schot CS, van Dijk A, van der Ende A, Schouls LM

Publikováno v: PloS one [PLoS One] 2011; Vol. 6 (5), pp. e20390. Date of Electronic Publication: 2011 May 26.